,,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny breast04', 'destiny,breast,4', 'breast', 'enhertu', '$dsnky', '$azn']
 both $azn and $dsnky have products and development projects beyond enhertu, but today's price action revolves around yesterday's asco destiny breast04 news and the expected impact or non-impact of it.
I value data, science & intelligent contributions (content+context).
If you don't, don't follow me & don't reply 2 my tweets.
Disclaimer: Not investment advice.